Send to

Choose Destination

See 1 citation found by title matching your search:

Front Public Health. 2019 Jan 31;7:4. doi: 10.3389/fpubh.2019.00004. eCollection 2019.

Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?

Author information

School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, NSW, Australia.
Faculty of Medicine, McGill University, Montreal, QC, Canada.
London School of Hygiene and Tropical Medicine, Bloomsbury, London, United Kingdom.
Jhpiego, Washington, DC, United States.
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine and Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW, Australia.
Mothers and Babies Research Centre, Hunter Medical Research Institute, New Lambton, NSW, Australia.
Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Division of Infectious Diseases and the Program in Global Health, Fielding School of Public Health, University of California Los Angeles Care Center, Los Angeles, CA, United States.
Department of Urology, University of Washington School of Medicine, Seattle, WA, United States.


Background: Male circumcision (MC) is proven to substantially reduce men's risk of a number of sexually transmitted infections (STIs). We conducted a detailed systematic review of the scientific literature to determine the relationship between MC and risk of STIs and associated conditions in women. Methods: Database searches by "circumcision women" and "circumcision female" identified 68 relevant articles for inclusion. Examination of bibliographies of these yielded 14 further publications. Each was rated for quality using a conventional rating system. Results: Evaluation of the data from the studies retrieved showed that MC is associated with a reduced risk in women of being infected by oncogenic human papillomavirus (HPV) genotypes and of contracting cervical cancer. Data from randomized controlled trials and other studies has confirmed that partner MC reduces women's risk not only of oncogenic HPV, but as well Trichomonas vaginalis, bacterial vaginosis and possibly genital ulcer disease. For herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, human immunodeficiency virus and candidiasis, the evidence is mixed. Male partner MC did not reduce risk of gonorrhea, Mycoplasma genitalium, dysuria or vaginal discharge in women. Conclusion: MC reduces risk of oncogenic HPV genotypes, cervical cancer, T. vaginalis, bacterial vaginosis and possibly genital ulcer disease in women. The reduction in risk of these STIs and cervical cancer adds to the data supporting global efforts to deploy MC as a health-promoting and life-saving public health measure and supplements other STI prevention strategies.


HIV; HPV; circumcision; male; preventive medicine; public health; sexually transmitted infections; women

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center